Navigation Links
GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine
Date:2/12/2010

WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- The Georgetown Lombardi Comprehensive Cancer Center hosts a symposium exploring the future of cancer research on Feb. 17th at Georgetown University Medical Center (GUMC).  Sponsored by the Ruesch Center for the Cure of Gastrointestinal Cancers, the two-part symposium, "Fighting a Smarter War Against Cancer: Personalized Medicine & the Cure for Cancer," will offer a focus on personalized medicine by bringing together experts in academia, industry and advocacy.  The two-part symposium from 2:00 to 6:30 p.m. is open to the public.  

The first part of the symposium discusses the scientific basis for personalized medicine, while the second brings in voices from pharmaceutical industries, bioethics and patient advocacy. Guest speakers include Carolyn "Bo" Aldige, president and founder of Prevent Cancer Foundation; Mace Rothenberg, MD, senior vice president of Pfizer Oncology; Carol Taylor, Ph.D., MSN, director of the Center for Clinical Bioethics at GUMC; and the Hon. W.J. (Billy) Tauzin, president and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA).  Rothenberg will deliver the annual Thomas R. Schafer Memorial Lecture in Pancreatic and Gastrointestinal Cancer.

The symposium builds on the philosophy of the director of the Ruesch Center, John L. Marshall, MD, a leading gastrointestinal oncologist who advocates re-invigorating the war on cancer by focusing research on a cure, not incremental improvements.  He recently wrote about his views on cancer research in the Washington Post (Nov. 29, 2009). "Fighting a smarter war on cancer," describes the need "to wage a smarter, more personalized war against cancer instead of settling for a standard of care with high costs and minor progress."  

"The problem in cancer medicine is that we have very little evidence to support what we are doing," Marshall says. "We must further explore the genetic makeup of patients and their cancers. We can no longer diagnose cancers using only a microscope. We must profile them at a molecular level to determine precise treatments, instead of using our current trial-and-error approach."

To register for the symposium or for more information, visit the Lombardi website http://lombardi.georgetown.edu/GI, or call 202-687-2956.  Members of the media should contact Karen Mallet at km463@georgetown.edu.

About Lombardi Comprehensive Cancer Center

The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.

About Georgetown University Medical Center

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through Georgetown's affiliation with MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding. 

SOURCE Georgetown University Medical Center

RELATED LINKS
http://www.gumc.georgetown.edu
http://lombardi.georgetown.edu

'/>"/>

SOURCE Georgetown University Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Lombardis Shields leads special journal focused on tobacco research
2. Medical University of South Carolina Automates Grants Allocation Process with Lombardi Business Process Management Software
3. Georgetowns Lombardi Comprehensive Cancer Center and the Capital Breast Care Center Pound the Pavement to Save Lives
4. Lombardi Cancer Center and the Capital Breast Care Center awarded $750,000 from the AVON Foundation
5. V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetowns Lombardi Comprehensive Cancer Center
6. NICHD Deploying Lombardi Business Process Management (BPM) Suite
7. Lombardi Comprehensive Cancer Center publishes manual for childhood cancer survivors
8. Lombardi Cancer Centers Toretsky awarded prestigious Burroughs Wellcome Fund Award
9. Centene Corporation Hosts Medical Management Systems Update in New York City
10. Arthur M. Blank Family Foundation Hosts Author of Last Child in the Woods: Saving our Children from Nature-Deficit Disorder
11. BayCare Hosts Public Events to Celebrate American Heart Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced ... counsel and Eric Hoessel to vice president of sales. , Litsinger joined ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... version gives development continuity to its innovative Unified Instance Manager architecture, meeting ... In addition, this new version optimizes the unattended auto-dialing system without agents, ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
(Date:12/8/2016)... global biosurgery market is expected to grow at a ... to 2021. The market is poised to reach USD ... 2016. The market is primarily driven by rising number ... spinal problems, increasing clearance of biosurgery products by regulatory ... In this report, the biosurgery market is ...
(Date:12/8/2016)... Pharmacy, Inc. (NYSE: DPLO) has been recognized by the Detroit ... Standard. To learn more about Diplomat,s career opportunities, visit ... ... ... LLC, a research firm specializing in organizational health and workplace improvement. ...
Breaking Medicine Technology: